COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic …
respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic …
Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis
… Author links open overlay panel David Jiménez MD, PhD a b c , Aldara García-Sanchez
MD a , Parth Rali MD d , Alfonso Muriel MD, PhD e , Behnood Bikdeli MD f g h , Pedro Ruiz-…
MD a , Parth Rali MD d , Alfonso Muriel MD, PhD e , Behnood Bikdeli MD f g h , Pedro Ruiz-…
[HTML][HTML] Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research
…, MV Madhavan, A Gupta, D Jimenez… - Thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The suspected …
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The suspected …
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary …
…, Document Reviewers, Ç Erol, D Jimenez… - European heart …, 2014 - academic.oup.com
The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …
research, but also the creation of educational tools and implementation programmes for the …
Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report
Background We update recommendations on 12 topics that were in the 9th edition of these
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak (…
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak (…
[HTML][HTML] Fibrinolysis for patients with intermediate-risk pulmonary embolism
…, A Geibel, SZ Goldhaber, D Jimenez… - … England Journal of …, 2014 - Mass Medical Soc
Background The role of fibrinolytic therapy in patients with intermediate-risk pulmonary
embolism is controversial. Methods In a randomized, double-blind trial, we compared …
embolism is controversial. Methods In a randomized, double-blind trial, we compared …
Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among …
… The only exception was baseline D-dimer, which was not available in 66.5% of the patients
at baseline due to unprecedented national increase in use of D-dimer assays leading to …
at baseline due to unprecedented national increase in use of D-dimer assays leading to …
Development of a risk prediction score for occult cancer in patients with VTE
Background The benefits of a diagnostic workup for occult cancer in patients with VTE are
controversial. Our aim was to provide and validate a risk score for occult cancer in patients …
controversial. Our aim was to provide and validate a risk score for occult cancer in patients …
[HTML][HTML] Artificial intelligence, systemic risks, and sustainability
… D. Garcia’s work was supported by the Vienna Science and Technology Fund (Grant No.
VRG16… D. Farber’s work was supported by the College of Engineering, Penn State University. T. …
VRG16… D. Farber’s work was supported by the College of Engineering, Penn State University. T. …
Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report
Background Emerging evidence shows that severe coronavirus disease 2019 (COVID-19)
can be complicated by a significant coagulopathy, that likely manifests in the form of both …
can be complicated by a significant coagulopathy, that likely manifests in the form of both …